Boston Scientific Corporation Reports Q4 EPS of $.15 vs. $.10; Revenues $2.002B vs. $1.99B

by Benzinga Staff

February 1, 2011 5:03 PM | 14 seconds read | Make a Comment

Boston Scientific Corporation

BSX

today announced financial results for the fourth quarter and full year ended December 31, 2010. Fourth quarter sales were $2.002 billion with GAAP earnings of $0.15 per diluted share and adjusted earnings per diluted share of $0.20.

Market News and Data brought to you by Benzinga APIs

Posted In: Earnings News Health Care Health Care Equipment

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Boston Scientific Corporation Reports Q4 EPS of $.15 vs. $.10; Revenues $2.002B vs. $1.99B